You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 5, May 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chloracne From Manufacture of a New Herbicide

James S. Taylor, MD; Richard C. Wuthrich, MD; Kenneth M. Lloyd, MD; Alan Poland, MD

Arch Dermatol. 1977;113(5):616-619.


Abstract

• Forty-one chemical company workers had chloracne as a result of exposure to 3,4,3',4'-tetrachloroazoxybenzene (TCAB), an extraneous intermediate produced during the manufacture of a new herbicide. There was no laboratory evidence of significant hepatotoxicity or porphyria during the short time the herbicide was produced. An acnegenic when applied to the rabbit ear, TCAB is also a potent inducer of the microsomal enzyme aryl hydrocarbon hydroxylase. Prevention of chloracne is a difficult industrial engineering task and treatment of the disease is even more perplexing.

(Arch Dermatol 113:616-619, 1977)



Author Affiliations

From the Section of Industrial Dermatology, Department of Dermatology, Cleveland Clinic Foundation and Cleveland Clinic Educational Foundation, Ohio (Drs Taylor and Wuthrich), and Department of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, New York (Dr Poland). Dr Lloyd is in private practice in Youngstown, Ohio.


Footnotes

Accepted for publication July 23, 1976.

Read before the Section on Dermatology at the 123rd annual convention of the American Medical Association, Chicago, June 24, 1974.

Reprint requests to Section of Industrial Dermatology, Department of Dermatology, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44106 (Dr Taylor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyperkeratosis induced by sunlight degradation products of the major polybrominated biphenyl in Firemaster
Patterson et al.
Science 1981;213:901-902.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.